Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke
Restricted accessResearch articleFirst published online January, 2017
Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke
To determine the appropriate treatments for post-ischaemic stroke depression at different times after stroke.
Design:
A single-blind, randomized, controlled trial that compared three intervention groups, with subgroups stratified by time after stroke.
Setting:
Outpatient clinic.
Subjects:
Eligible patients were recruited at discharge (n = 73) and three (n = 67), six (n = 65), and nine months (n = 69) after discharge, and patients completed mood questionnaires.
Interventions:
Patients were randomly distributed into three groups: Group A received placebos and participated in general discussions; Group B, received citalopram and participated in general discussions; and Group C, received placebos and underwent cognitive behavioural therapy. All three groups participated in rehabilitation during three months of follow-up.
Main measures:
Outcome was assessed three months after baseline using the 17-item Hamilton Depression Scale (HAMD17) and the Bech–Rafaelsen Melancholia Scale (MES). During treatment, the Udvalg for Kliniske Undersogelser side-effect scale was also administered.
Results:
When stratification was not considered, the scores of Group B on the Melancholia Scale were lower than those of Group A (P = 0.02); when the four time-based subgroups were analysed, significant differences were observed between Groups A and B (PMES = 0.02, PHAMD17 = 0.02) in the group recruited six months after discharge and between Groups A and C (PMES = 0.01) in the last time period nine months after discharge.
Conclusions:
The effects of citalopram or cognitive behavioural therapy is similar to the effect of rehabilitation alone for early-onset post-ischaemic depression; rehabilitation and citalopram for delayed-onset post-ischaemic depression; and rehabilitation and cognitive behavioural therapy for late-onset post-ischaemic depression are more effective than rehabilitation alone.
Taylor-PiliaeREHepworthJTCoullBM. Predictors of depressive symptoms among community-dwelling stroke survivors. J Cardiovasc Nurs2013; 28: 460–467.
2.
HackettMLAndersonCSHouseAHaltehC. Interventions for preventing depression after stroke. The Cochrane Database System Rev2008: CD003689.
3.
HackettMLAndersonCSHouseAXiaJ. Interventions for treating depression after stroke. The Cochrane Database System Rev2008: CD003437.
4.
LimCMKimSWParkJYKimCYoonSHLeeJK. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res2009; 87: 1037–1045.
5.
ShinTKKangMSLeeHY. Fluoxetine and sertraline attenuate postischemic brain injury in mice. Korean J Physiol Pharmacol2009; 13: 257–263.
6.
CoppellALPeiQZetterstromTS. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacol2003; 44: 903–910.
7.
Russo-NeustadtAABeardRCHuangYMCotmanCW. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience2000; 101: 305–312.
8.
AndersonCSHackettMLHouseAO. Interventions for preventing depression after stroke. The Cochrane Database System Rev2004: CD003689.
9.
AnsonKPonsfordJ. Evaluation of a coping skills group following traumatic brain injury. Brain Inj2006; 20: 167–178.
10.
BedardMFelteauMMazmanianD. Pilot evaluation of a mindfulness-based intervention to improve quality of life among individuals who sustained traumatic brain injuries. Disabil Rehabil2003; 25: 722–731.
11.
HackettMLAndersonCSHouseAO. Interventions for treating depression after stroke. The Cochrane Database System Rev2004: CD003437.
KootkerJARasquinSMSmitsPGeurtsACvan HeugtenCMFasottiL. An augmented cognitive behavioural therapy for treating post-stroke depression: Description of a treatment protocol. Clin Rehabil2015; 29: 833–843.
14.
KlausnerEJClarkinJFSpielmanLPupoCAbramsRAlexopoulosGS. Late-life depression and functional disability: The role of goal-focused group psychotherapy. Int J Geriatr Psychiatry1998; 13: 707–716.
15.
ZedlitzAMRietveldTCGeurtsACFasottiL. Cognitive and graded activity training can alleviate persistent fatigue after stroke: A randomized, controlled trial. Stroke2012; 43: 1046–1051.
16.
ArseniouSArvanitiASamakouriM. [Post-stroke depression: Recognition and treatment interventions]. Psychiatriki2011; 22: 240–248.
17.
HouWHLiangHWHsiehCLHouCYWenPCLiCY. Effects of stroke rehabilitation on incidence of poststroke depression: A population-based cohort study. J Clin Psychiatry2013; 74: e859–866.
18.
StrandTAsplundKErikssonSHaggELithnerFWesterPO. A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke1985; 16: 29–34.
19.
ErikssonSAsplundKHaggELithnerFStrandTWesterPO. Clinical profiles of cerebrovascular disorders in a population-based patient sample. J Chronic Dis1987; 40: 1025–1032.
20.
BeckASteerRBrownG. Beck Depression Inventory Manual. San Antonio, Texas, 1996.
21.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington: American Psychiatric Association, 1994.
22.
RampelloLChiechioSNicolettiG. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacol2004; 173: 73–78.
23.
SondergaardMPJardenJOMartinyKAndersenGBechP. Dose response to adjunctive light therapy in citalopram-treated patients with post-stroke depression. A randomised, double-blind pilot study. Psychother Psychosom2006; 75: 244–248.
24.
BechPTanghojPAndersenHFOveroK. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacol2002; 163: 20–25.
25.
LincolnNBFlannaghanTSutcliffeLRotherL. Evaluation of cognitive behavioural treatment for depression after stroke: A pilot study. Clin Rehabil1997; 11: 114–122.
26.
BechPKastrupMRafaelsenOJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl1986; 326: 1–37.
27.
LingjaerdeOAhlforsUGBechPDenckerSJElgenK. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl1987; 334: 1–100.
28.
MahoneyFIBarthelDW. Functional evaluation: The Barthel Index. MD State Med J1965; 14: 61–65.
29.
WhitlockJAJrHamiltonBB. Functional outcome after rehabilitation for severe traumatic brain injury. Arch Phys Med Rehabil1995; 76: 1103–1112.
30.
AndersenGVestergaardKLauritzenL. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke1994; 25: 1099–1104.
31.
ParkerGBlanchBPatersonA. The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: A 12-week single-blind randomized study. Acta Psychiatrica Scand2013; 128: 271–281.
32.
MohrDCHoJDuffecyJ. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: A randomized trial. Jama2012; 307: 2278–2285.
33.
LauritzenLBendsenBBVilmarTBendsenEBLundeMBechP. Post-stroke depression: Combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacol1994; 114: 119–122.
34.
GustafsonYNilssonIMattssonMAstromMBuchtG. Epidemiology and treatment of post-stroke depression. Drugs Aging1995; 7: 298–309.
35.
KauhanenMKorpelainenJTHiltunenP. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke1999; 30: 1875–1880.
36.
BurvillPJohnsonGJamrozikKAndersonCStewart-WynneE. Risk factors for post-stroke depression. Int J Geriatr Psychiatry1997; 12: 219–226.
37.
NeauJPIngrandPMouille-BrachetC. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis1998; 8: 296–302.
38.
ChenYGuoJJZhanSPatelNC. Treatment effects of antidepressants in patients with post-stroke depression: A meta-analysis. Ann Pharmacother2006; 40: 2115–2122.
39.
PaolucciSAntonucciGGrassoMG. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis2001; 12: 264–271.
40.
FedoroffJPRobinsonRG. Tricyclic antidepressants in the treatment of poststroke depression. J Clin Psychiatry1989; 50(Suppl): 18–23; discussion 4–6.
41.
GainottiGAntonucciGMarraCPaolucciS. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol, Neurosurg, Psychiatry2001; 71: 258–261.
42.
LincolnNBFlannaghanT. Cognitive behavioral psychotherapy for depression following stroke: A randomized controlled trial. Stroke2003; 34: 111–115.
